苯磺酸左旋氨氯地平
Tier C — Watch / tradeLevamlodipine Besylate
Targets:VDCCs
Brand:Levotension
Indications (approved):高血压、心绞痛
Regional status
Synthetic routes & intermediates5 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| Levamlodipine Besylate-001 | 111470-99-6,88150-42-9 | (±)-2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine |
| Levamlodipine Besylate-002 | - | Bis[3-ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate] (2S,3S)-2,3-dihydroxybutanedioic acid urea |
| Levamlodipine Besylate-003 | 103129-82-4 | 3-Ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine Besylate-004 | - | (2S,3S)-2,3-Dihydroxybutanedioic acid 3-ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (1/2) |
| Levamlodipine Besylate-005 | - | (2R,3R)-2,3-Dihydroxybutanedioic acid 3-ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (1/2) |

| Code | CAS No. | Intermediate |
|---|---|---|
| Levamlodipine Besylate-006 | 221446-45-3 | 3-Ethyl 5-methyl 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine Besylate-007 | 906098-03-1 | 5-Ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[(2-nitroethoxy)methyl]-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine Besylate-001 | 111470-99-6,88150-42-9 | (±)-2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine |
| Levamlodipine Besylate-008 | 88150-75-8 | Ethyl 4-(2-phthalimidoethoxy)acetoacetate |
| Levamlodipine Besylate-009 | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| Levamlodipine Besylate-010 | 89-98-5 | 2-Chlorobenzaldehyde |
| Levamlodipine Besylate-011 | 103094-30-0,88150-62-3 | 3-Ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |

| Code | CAS No. | Intermediate |
|---|---|---|
| Levamlodipine Besylate-012 | - | 1-tert-Butyl 3-ethyl 5-methyl 2-([2-[(tert-butoxycarbonyl)amino]ethoxy]methyl)-6-methylpyridine-1,3,5(4H)-tricarboxylate |
| Levamlodipine Besylate-013 | 615-41-8 | 1-Chloro-2-iodobenzene |
| Levamlodipine Besylate-014 | - | 2-(2-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
| Levamlodipine Besylate-015 | - | 2-(2-Chlorophenyl)-4,4-dimethyl-1,3,2-dioxaborolane |
| Levamlodipine Besylate-016 | - | 2-(2-Chlorophenyl)-1,3,2-dioxaborolane |
| Levamlodipine Besylate-017 | - | 1-tert-Butyl 3-ethyl 5-methyl 2-([2-[(tert-butoxycarbonyl)amino]ethoxy]methyl)-4-(2-chlorophenyl)-6-methylpyridine-1,3,5(4H)-tricarboxylate |
| Levamlodipine Besylate-001 | 88150-42-9,111470-99-6 | (±)-2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine |

| Code | CAS No. | Intermediate |
|---|---|---|
| Levamlodipine Besylate-001 | 111470-99-6,88150-42-9 | (±)-2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine |
| Levamlodipine Besylate-018 | - | (4S)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (2Z)-but-2-enedioic acid 3-ethyl 5-methyl |

| Code | CAS No. | Intermediate |
|---|---|---|
| Levamlodipine Besylate-019 | 147357-20-8 | 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, 3-ethyl 5-methyl ester |
| Levamlodipine Besylate-020 | - | 3-ethyl 5-methyl 4-bromo-2-(bromomethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine Besylate-021 | 3891-07-4 | N-Hydroxyethylphthalimide |
| Levamlodipine Besylate-022 | - | 3-ethyl 5-methyl 4-bromo-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine Besylate-023 | 3900-89-8 | 2-Chlorophenylboronic acid |
| Levamlodipine Besylate-024 | 88150-62-3 | Phthaloyl amlodipine |
| Levamlodipine Besylate-001 | 88150-42-9,111470-99-6 | (±)-2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine |
Frequently asked questions
What are the approved indications of Levamlodipine Besylate?
Approved indications include: 高血压, 心绞痛.
When does the Levamlodipine Besylate patent expire?
No public expiry year is available for Levamlodipine Besylate yet; this page updates once verified.
How many synthesis routes are recorded for Levamlodipine Besylate?
5 synthesis routes are recorded; the shortest is 1 steps with 17.8g(Levamlodipine Maleate (API)) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Levamlodipine Besylate intermediates?
All intermediates in Levamlodipine Besylate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Levamlodipine Besylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24